CI vs CVS
Cigna and CVS Health, both Healthcare
CVS Health is the larger company at $125B against $74B. On trailing earnings CI is the cheaper of the two at a P/E of 11.7 against 22.7, a gap that is only a bargain if the two are growing at similar rates. Over the past year CVS returned +19% against -2.2% for CI. The RyuScore puts CI ahead, 73 against 54 out of 100.
| Figure | CI | CVS |
|---|---|---|
| Last close | $282 | $86.18 |
| Market cap | $74B | $125B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 11.7 | 22.7 |
| Dividend yield | 2.1% | 3.2% |
| 1-year return | -2.2% | +19% |
| 5-year return | +47% | +20% |
| RyuScoresector-relative, 1–10 | 73/100 | 54/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Cigna
Revenue of $72B in Q2 2026, net income $1.9B. Its largest reported line is Network Pharmacy, 50% of the disclosed total.
CVS Health
Revenue of $106B in Q2 2026, net income $3.0B. Its largest reported line is Health Services, 42% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.